Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.
2.
3.
4.

Comparison of rosiglitazone and metformin for treating HIV lipodystrophy: a randomized trial.

van Wijk JP, de Koning EJ, Cabezas MC, op't Roodt J, Joven J, Rabelink TJ, Hoepelman AI.

Ann Intern Med. 2005 Sep 6;143(5):337-46. Erratum in: Ann Intern Med. 2005 Nov 1;143(9):695. Dosage error in published abstract; MEDLINE/PubMed abstract corrected.

PMID:
16144892
5.

Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome.

Derosa G, D'Angelo A, Ragonesi PD, Ciccarelli L, Piccinni MN, Pricolo F, Salvadeo SA, Montagna L, Gravina A, Ferrari I, Paniga S, Cicero AF.

J Clin Pharm Ther. 2006 Aug;31(4):375-83.

PMID:
16882108
6.

Rosiglitazone in the treatment of HAART-associated lipodystrophy--a randomized double-blind placebo-controlled study.

Sutinen J, Häkkinen AM, Westerbacka J, Seppälä-Lindroos A, Vehkavaara S, Halavaara J, Järvinen A, Ristola M, Yki-Järvinen H.

Antivir Ther. 2003 Jun;8(3):199-207.

PMID:
12924536
7.

Growth hormone axis treatments for HIV-associated lipodystrophy: a systematic review of placebo-controlled trials.

Sivakumar T, Mechanic O, Fehmie DA, Paul B.

HIV Med. 2011 Sep;12(8):453-62. doi: 10.1111/j.1468-1293.2010.00906.x. Epub 2011 Jan 25. Review.

8.

Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation.

Waugh N, Cummins E, Royle P, Clar C, Marien M, Richter B, Philip S.

Health Technol Assess. 2010 Jul;14(36):1-248. doi: 10.3310/hta14360. Review.

9.

A meta-analysis comparing the effect of thiazolidinediones on cardiovascular risk factors.

Chiquette E, Ramirez G, Defronzo R.

Arch Intern Med. 2004 Oct 25;164(19):2097-104.

PMID:
15505122
10.

Metabolic effects of rosiglitazone in HIV lipodystrophy: a randomized, controlled trial.

Hadigan C, Yawetz S, Thomas A, Havers F, Sax PE, Grinspoon S.

Ann Intern Med. 2004 May 18;140(10):786-94.

PMID:
15148065
11.

Metformin in the treatment of HIV lipodystrophy syndrome: A randomized controlled trial.

Hadigan C, Corcoran C, Basgoz N, Davis B, Sax P, Grinspoon S.

JAMA. 2000 Jul 26;284(4):472-7.

PMID:
10904511
13.

A systematic review and meta-analysis of randomized controlled trials comparing pioglitazone versus metformin in the treatment of polycystic ovary syndrome.

Du Q, Wang YJ, Yang S, Wu B, Han P, Zhao YY.

Curr Med Res Opin. 2012 May;28(5):723-30. doi: 10.1185/03007995.2012.681636. Epub 2012 Apr 19. Review.

PMID:
22462531
14.

Metformin and glitazones: do they really help PCOS patients?

Pillai A, Bang H, Green C.

J Fam Pract. 2007 Jun;56(6):444-53. Review.

PMID:
17543254
15.

Effects of metformin and rosiglitazone in HIV-infected patients with hyperinsulinemia and elevated waist/hip ratio.

Mulligan K, Yang Y, Wininger DA, Koletar SL, Parker RA, Alston-Smith BL, Schouten JT, Fielding RA, Basar MT, Grinspoon S.

AIDS. 2007 Jan 2;21(1):47-57.

PMID:
17148967
18.

Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients.

Rosenstock J, Sugimoto D, Strange P, Stewart JA, Soltes-Rak E, Dailey G.

Diabetes Care. 2006 Mar;29(3):554-9.

PMID:
16505505
19.
20.

Effects of metformin or gemfibrozil on the lipodystrophy of HIV-infected patients receiving protease inhibitors.

Martínez E, Domingo P, Ribera E, Milinkovic A, Arroyo JA, Conget I, Pérez-Cuevas JB, Casamitjana R, de Lazzari E, Bianchi L, Montserrat E, Roca M, Burgos R, Arnaiz JA, Gatell JM.

Antivir Ther. 2003 Oct;8(5):403-10.

PMID:
14640387
Items per page

Supplemental Content

Write to the Help Desk